Ep 27 Weighing the Scales: Risk vs. Benefit of GLP-1 Drugs

In this episode, we break down GLP-1 agonists (like semaglutide and tirzepatide): Their strengths for weight loss and heart health, common side effects and long-term unknowns (including emerging vision risks), and how studies from the US and Europe paint a balanced picture. Focused on what matters for women navigating these options—backed by research and real experiences. (Always consult your doctor for personalized advice!)

Key Takeaways:

• GLP-1 drugs offer solid support for weight loss, better blood sugar control, and may reduce heart risks, especially when started gently and paired with healthy habits.
• Side effects like nausea are common but often manageable; rarer issues include muscle loss, bone health concerns, and very low-risk vision problems—monitor with your doctor.
• Global data shows US approvals emphasize BMI cutoffs, while Europe stresses holistic use for better results and fewer downsides.
• Weekly Challenge: Create a Pros-Cons Balance Sheet—list one benefit and risk of GLP-1 for your life. Share for community spotlights!

Join my free unDIETING 101 5-Day Bootcamp! I'll show you how to unlearn dieting and lose weight for good. 🙌

🔗 Sign up now

References & Sources

For a full list of references and sources used in this episode (including studies, financial reports, and expert analyses), visit the dedicated References on the podcast website.

Disclaimer:

The insights and tips shared in this podcast are based on my personal journey and are for informational and motivational purposes only. They are not intended as a substitute for professional medical advice. If you have specific health concerns or questions related to your medical condition, please consult with your healthcare provider. Remember, your health journey is unique, and what has worked for me might not be suitable for everyone. The content here does not aim to diagnose, treat, cure, or prevent any disease, and results from following the strategies discussed can vary.